Encapsulated allogeneic FVIII cell therapy

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Encapsulated allogeneic FVIII cell therapy, covering 2024-09-04 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A [Phase 1, Phase 2]